143415-62-7 Usage
General Description
BOC-L-4-tert-butyl-Phe, also known as (S)-tert-butyl 4-((tert-butoxycarbonyl)amino)phenylalaninate, is a chemical compound used in the synthesis of peptides and pharmaceuticals. It is a protected amino acid derivative, where the tert-butyl group serves as a protecting group that can be removed under specific conditions. BOC-L-4-TERT-BUTYL-PHE is often used in peptide chemistry to introduce the amino acid phenylalanine into a peptide chain with protection from unwanted reactions. BOC-L-4-tert-butyl-Phe is widely utilized in the pharmaceutical industry for the production of various pharmaceutical compounds and is a vital building block in the synthesis of diverse peptide-based drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 143415-62-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,4,1 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 143415-62:
(8*1)+(7*4)+(6*3)+(5*4)+(4*1)+(3*5)+(2*6)+(1*2)=107
107 % 10 = 7
So 143415-62-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H27NO4/c1-17(2,3)13-9-7-12(8-10-13)11-14(15(20)21)19-16(22)23-18(4,5)6/h7-10,14H,11H2,1-6H3,(H,19,22)(H,20,21)/t14-/m1/s1
143415-62-7Relevant articles and documents
ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS
-
Page/Page column 243; 244, (2018/06/06)
The present invention provides cyclic depsipeptide compounds of formula (I) wherein the stereochemical configuration of at least one carbon atom bearing the groups Cy1, Cy2, R1, R2, R3, R4, Ra and Rb is inverted compared with the naturally occurring cyclic depsipeptide PF1022A. The invention also provides compositions comprising the compounds that are effective against parasites that harm animals. The compounds and compositions may be used for combating parasites in or on mammals and birds. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation in birds and mammals.
CCK ANALOGS WITH APPETITE REGULATING ACTIVITY
-
, (2008/06/13)
The invention is directed to novel CCK analogs wherein Tryptophan and/or Phenylalamine are substituted with a radical which provides enhanced appetite suppressant activity to the peptide.